Broughton has been engaged in collaborative discussions with the European Directorate for the...
New Faces, New Focus: How FDA’s 2025 Shake-Up Could Redefine Tobacco Regulation
Since January 2025, the regulatory landscape for tobacco and nicotine products in the United States has experienced one of the most significant transformations in recent memory. Following the inauguration of a new administration, the U.S. Food and...
All articles
When developing a nicotine product, the choice between freebase nicotine and nicotine salts plays a...
Chromatography is a cornerstone of analytical testing for nicotine products. It allows us to...
In the evolving world of cannabis science, terpenes are stepping out of the background. These...
Our Chief Commercial Officer, Andy Mooney, recently attended the Global Forum on Nicotine (GFN)...
Why MMAD Testing Matters in Inhalation Product Development
Bringing a medical device to market isn’t just about innovation—it’s about precision, compliance,...
The Next Generation Nicotine Delivery (NGND) conference in Miami delivered an energetic and...
Introduction: Preparing for Regulatory Change in the Vape Industry
If you have a specific question for one of our scientific or regulatory experts, get in touch with a member of our team today.
